Prelude Capital Management, LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $131,199 - $206,747	-10,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $193,299 - $377,500	10,000 Added 10000.0%	10,100 $233,000
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $7,818 - $10,688	-200 Reduced 66.67%	100 $4,000
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $9,340 - $18,408	-200 Reduced 40.0%	300 $14,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $45,915 - $60,340	500 New	500 $56,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.